Linked Life Data

16910628

Source:http://linkedlifedata.com/resource/pubmed/id/16910628

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16910628rdf:typepubmed:Citationlld:pubmed
pubmed-article:16910628lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16910628lifeskim:mentionsumls-concept:C0003289lld:lifeskim
pubmed-article:16910628lifeskim:mentionsumls-concept:C0011570lld:lifeskim
pubmed-article:16910628lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:16910628pubmed:issue2 Pt 1lld:pubmed
pubmed-article:16910628pubmed:dateCreated2006-8-16lld:pubmed
pubmed-article:16910628pubmed:abstractTextDepression is common in people with schizophrenia and is associated with substantial morbidity explaining also the considerable attention and recognition of this entity as suggested by the inclusion of the post-psychotic depression in DSM IV and ICD 10. The prevalence of this disorder varies according to the type of approach used (range between 7% to 75%). Prescription of antidepressants plus antipsychotic treatment is frequent in clinical practice (11 to 43%).lld:pubmed
pubmed-article:16910628pubmed:languagefrelld:pubmed
pubmed-article:16910628pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16910628pubmed:citationSubsetIMlld:pubmed
pubmed-article:16910628pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16910628pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16910628pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16910628pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16910628pubmed:statusMEDLINElld:pubmed
pubmed-article:16910628pubmed:issn0013-7006lld:pubmed
pubmed-article:16910628pubmed:authorpubmed-author:BlinOOlld:pubmed
pubmed-article:16910628pubmed:authorpubmed-author:MicallefJJlld:pubmed
pubmed-article:16910628pubmed:authorpubmed-author:FakraEElld:pubmed
pubmed-article:16910628pubmed:issnTypePrintlld:pubmed
pubmed-article:16910628pubmed:volume32lld:pubmed
pubmed-article:16910628pubmed:ownerNLMlld:pubmed
pubmed-article:16910628pubmed:authorsCompleteYlld:pubmed
pubmed-article:16910628pubmed:pagination263-9lld:pubmed
pubmed-article:16910628pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16910628pubmed:meshHeadingpubmed-meshheading:16910628...lld:pubmed
pubmed-article:16910628pubmed:meshHeadingpubmed-meshheading:16910628...lld:pubmed
pubmed-article:16910628pubmed:meshHeadingpubmed-meshheading:16910628...lld:pubmed
pubmed-article:16910628pubmed:meshHeadingpubmed-meshheading:16910628...lld:pubmed
pubmed-article:16910628pubmed:meshHeadingpubmed-meshheading:16910628...lld:pubmed
pubmed-article:16910628pubmed:meshHeadingpubmed-meshheading:16910628...lld:pubmed
pubmed-article:16910628pubmed:meshHeadingpubmed-meshheading:16910628...lld:pubmed
pubmed-article:16910628pubmed:meshHeadingpubmed-meshheading:16910628...lld:pubmed
pubmed-article:16910628pubmed:meshHeadingpubmed-meshheading:16910628...lld:pubmed
pubmed-article:16910628pubmed:articleTitle[Use of antidepressant drugs in schizophrenic patients with depression].lld:pubmed
pubmed-article:16910628pubmed:affiliationCPCET et Pharmacologie Clinique, Institut des Neurosciences Cognitives de la Mediterranée, Faculté de Médecine, UMR 6193, CNRS, Université de la Méditerranée, Assistance Publique - Hôpitaux de Marseille, Hôpital de la Timone, 13385 Marseille cedex 5.lld:pubmed
pubmed-article:16910628pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16910628pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:16910628pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16910628lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16910628lld:pubmed